ABSTRACT
Background This study aimed to assess the prevalence of glycemic fluctuations, fatigue, and sleep disturbances during Ramadan, and to identify factors associated with hypoglycemia and hyperglycemia events in this period.
Methods A cross-sectional study of 88 individuals with type 2 diabetes during Ramadan fasting (March-April 2024) was conducted. HbA1c levels before Ramadan were obtained from medical records. Participants monitored blood glucose twice daily (during the day and two hours after breaking fast). Blood glucose under 70 mg/dl was considered hypoglycemia, and over 200 mg/dl was hyperglycemia. Fatigue and sleep quality were assessed using the Indonesian Multidimensional Fatigue Inventory-20 (IMFI-20) and the Pittsburgh Sleep Quality Index (PSQI).
Results A total of 88 patients with type 2 diabetes (mean age, 52.7 years) participated, predominantly female (68.2%) and married (63.6%). The study found a prevalence of 21.6% for hypoglycemia and 30.6% for hyperglycemia. Additionally, 30.7% of participants experienced fatigue, and 40.9% reported poor sleep quality. HbA1c levels before Ramadan and fatigue were significantly associated with both hypoglycemia and hyperglycemia (p < 0.05). Sleep quality was also significantly associated with hyperglycemia events (p < 0.05).
Conclusion The study found that hypoglycemia and hyperglycemia are common in individuals with type 2 diabetes during Ramadan. Fatigue and poor sleep quality were also prevalent.
Significant factors linked to both glycemic events included pre-Ramadan HbA1c levels and fatigue, while sleep quality was associated with hyperglycemia. These findings emphasize the need for targeted interventions and personalized management to reduce glycemic fluctuations and improve well-being during Ramadan fasting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research received approval from the Joint Institutional Review Board of the Ethical Committee of Medical Research at the Faculty of Dentistry, University Jember (No.2458/UN25.8/KEPK/DL/2024).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
DATA AVAILABILITY STATEMENT
Specific data files used in the analysis are available from the corresponding author upon reasonable request.
